Price target
25.270.00 0.00%
The 7 analysts offering 1 year price forecasts for 038 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 7 analysts giving stock ratings to 038 in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
038 EPS for the last quarter is −0.33 EUR despite the estimation of −0.39 EUR. In the next quarter EPS is expected to reach −0.38 EUR. Track more of NOVOCURE LIMITED financials and stay on top of what is up with the company.
In the next quarter NOVOCURE LIMITED revenue is expected to reach 126.81 M EUR. Check out NOVOCURE LIMITED revenue and earnings and make informed decisions.
According to analysts, 038 price target is 25.27 EUR with a max estimate of 39.11 EUR and a min estimate of 18.62 EUR. Check if this forecast comes true in a year, meanwhile watch NOVOCURE LIMITED stock price chart and keep track of the current situation with 038 news and stock market news.
We've gathered opinions of 7 analysts rating 038 stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.